SARS-CoV-2 is not unique in its ability to cause post-acute sequelae; certain acute
infections have long been associated with an unexplained chronic disability in a minority of …

Chikungunya virus is widespread throughout the tropics, where it causes recurrent
outbreaks of chikungunya fever. In recent years, outbreaks have afflicted populations in East …

Methotrexate (MTX) is the first line drug for the treatment of a number of rheumatic and non-
rheumatic disorders. It is currently used as an anchor disease, modifying anti-rheumatic drug …

Chikungunya virus (CHIKV), a reemerging arbovirus, causes a crippling musculoskeletal
inflammatory disease in humans characterized by fever, polyarthralgia, myalgia, rash, and …

Background The acute phase of chikungunya is well documented; less so are its long-term
effects. This systematic literature review provides an overview of the currently available data …

Objective To determine the percentage of patients who would develop chronic inflammatory
rheumatism (CIR) following chikungunya (CHIK) virus disease. Methods We conducted a …

Rationale for review Chikungunya outbreaks continue to occur, with changing epidemiology.
Awareness about chikungunya is low both among the at-risk travellers and healthcare …

Background: Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that circulates
predominantly in tropical and subtropical regions, potentially affecting over 1 billion people …

Vector-borne diseases account for more than 17% of all infectious diseases. In the
Americas, dengue, chikungunya and Zika constitute a potential epidemiological risk due to …

In the past decade, arboviruses—arthropod‐borne viruses—have been the focus of public
health institutions worldwide following a spate of devastating outbreaks. Chikungunya virus …